SCHEMBL6805073

SCHEMBL6805073

Nc1ccc2c(c1)[C](O)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.38
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CASP1 P29466 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 2/20 0.36
TYMS P04818 1/20 0.36
BRD4 O60885 1/20 0.36
ATAD2 Q6PL18 1/20 0.36
PKM P14618 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11997405 0.76 MAPT (0.37) KDM4EMAPTALDH1A1CASP1NPC1
SCHEMBL656011 0.76 CASP1 (0.55) MAPTALDH1A1CASP1NPC1LMNA
SCHEMBL30067461 0.76 CASP1 (0.55) MAPTALDH1A1CASP1NPC1LMNA
SCHEMBL14409505 0.76 HPGD (0.53) KDM4EMAPTALDH1A1CASP1NPC1
SCHEMBL42805 0.73 CA12 (0.48) KDM4EMAPTALDH1A1CASP1NPC1
SCHEMBL29779691 0.73 CA12 (0.48) KDM4EMAPTALDH1A1CASP1NPC1
SCHEMBL4878376 0.72 CASP1 (0.55) MAPTALDH1A1CASP1NPC1LMNA
SCHEMBL6797539 0.72 KDM4E (0.48) KDM4EMAPTALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL2476978 0.72 CA12 (0.47) KDM4EMAPTALDH1A1CASP1NPC1
SCHEMBL7471741 0.71 CASP1 (0.59) PDE10AKDM4EMAPTALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750243-B1 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis AstraZeneća AB (SE) 2004-06-15 US claimed